Ardelyx Inc (ARDX) - Financial Analysis Review - GlobalData - Company Reports

Ardelyx Inc (ARDX) - Financial Analysis Review

Ardelyx Inc (ARDX) - Financial Analysis Review - GlobalData - Company Reports
Ardelyx Inc (ARDX) - Financial Analysis Review
Published Nov 29, 2016
43 pages — Published Nov 29, 2016
Price US$ 125.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Ardelyx Inc (Ardelyx) is a clinical stage biopharmaceutical company that discovers, develops and commercializes small molecule therapeutics for treatment of cardio-renal, gastrointestinal and metabolic disorders. Its product portfolio comprises Tenapanor, RDX227675, RDX98940 and RDX013. The companys products are used for hyperphosphatemia in patients with end-stage renal disease; constipation-predominant irritable bowel syndrome (IBS-C); and hyperkalemia, in chronic kidney disease (CKD) patients. Ardelyx develops proprietary drug discovery and design platform to discover and design novel drug candidates such as tenapanor and others.

GlobalData's Ardelyx Inc (ARDX) - Financial Analysis Review provides a comprehensive insight into the company's history, business structure and operations. The report contains information on the company's key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years.

Ardelyx Inc Key Recent Developments:

Nov 07,2016: Ardelyx Reports Third Quarter 2016 Financial Results and Recent Progress
Oct 24,2016: Ardelyx Strengthens Executive Leadership with the Appointment of Reginald Seeto, MBBS, as Chief Operating Officer
Aug 08,2016: Ardelyx Reports Second Quarter 2016 Financial Results
Jun 07,2016: Ardelyx Appoints Robert Bazemore to Its Board of Directors
May 09,2016: Ardelyx Reports First Quarter 2016 Financial Results


This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
- Business description - A detailed description of the company's operations and business divisions.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as detailed business description and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's business, financial and operational performance. Financial ratios presented for major public companies in the report include; revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

  
Source:
Document ID
GDPH194355FA
Country
Industry
Ticker
ARDX=US
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Section 1 - About the Company41
Ardelyx Inc - Key Facts51
Ardelyx Inc - Key Employees61
Ardelyx Inc - Key Employee Biographies71
Ardelyx Inc - Major Products and Services81
Ardelyx Inc - Pharmaceutical Pipeline Products Data93
  Ardelyx Inc, Pipeline Products by Therapy Area91
  Ardelyx Inc, Pipeline Products by Development Phase102
Ardelyx Inc - History121
Ardelyx Inc - Locations And Subsidiaries131
  Head Office131
Section 2 Company Analysis141
Company Overview141
Ardelyx Inc - Key Competitors151
Section 3 Company Financial Ratios161
Financial Ratios - Capital Market Ratios161
Financial Ratios - Annual Ratios172
Performance Chart191
Financial Performance191
Financial Ratios - Interim Ratios201
Financial Ratios - Ratio Charts211
Section 4 Company s Lifesciences Financial Deals and Alliances222
  Ardelyx Inc, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016221
  Ardelyx Inc, Pharmaceuticals &Healthcare, Deals By Type, 2010 to YTD 2016231
Ardelyx Inc, Recent Deals Summary241
Section 5 Company s Recent Developments251
Nov 07, 2016: Ardelyx Reports Third Quarter 2016 Financial Results and Recent Progress251
Oct 24, 2016: Ardelyx Strengthens Executive Leadership with the Appointment of Reginald Seeto, MBBS, as Chief Operating Officer261
Aug 08, 2016: Ardelyx Reports Second Quarter 2016 Financial Results272
Jun 07, 2016: Ardelyx Appoints Robert Bazemore to Its Board of Directors291
May 09, 2016: Ardelyx Reports First Quarter 2016 Financial Results301
Mar 04, 2016: Ardelyx Reports Fourth Quarter and Full-Year 2015 Financial Results312
Jan 04, 2016: Ardelyx Strengthens Executive Leadership Team with the Appointment of Paul Korner, MD, MBA, as Executive Vice President and Chief Medical Officer331
Nov 12, 2015: Ardelyx Reports Third Quarter 2015 Financial Results342
Oct 26, 2015: Ardelyx Appoints William Bertrand, Jr. to Its Board of Directors361
Aug 12, 2015: Ardelyx Reports Second Quarter 2015 Financial Results372
Section 6 Appendix395
  Methodology391
  Ratio Definitions394
  About GlobalData431
  Contact Us431
  Disclaimer431

Table Of Contents

GlobalData - Company Reports—GlobalData is an industry analysis specialist, providing business information products and services. These high quality company reports are created via a large research and analysis capability, drawing from extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
GlobalData - Company Reports. "Ardelyx Inc (ARDX) - Financial Analysis Review" Nov 29, 2016. Alacra Store. Jun 26, 2019. <http://www.alacrastore.com/storecontent/GlobalData-Company-Reports/Ardelyx-Inc-ARDX-Financial-Analysis-Review-2087-63541>
  
APA:
GlobalData - Company Reports. (2016). Ardelyx Inc (ARDX) - Financial Analysis Review Nov 29, 2016. New York, NY: Alacra Store. Retrieved Jun 26, 2019 from <http://www.alacrastore.com/storecontent/GlobalData-Company-Reports/Ardelyx-Inc-ARDX-Financial-Analysis-Review-2087-63541>
  
US$ 125.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Company Profiles from one place.